Clinical Trial Update: Single Treatment of DaxibotulinumtoxinA for Injection in Adults With Isolated Cervical Dystonia (ASPEN-1) [Phase 3]

View source ↗

Summary

Phase 3 trial updating results for a single treatment of DaxibotulinumtoxinA for injection in adults with isolated cervical dystonia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Dystonia

Drugs mentioned

• DaxibotulinumtoxinA for Injection (daxibotulinumtoxinA)

Snippet

Sponsor: Revance Therapeutics, Inc. | Conditions: Cervical Dystonia | Phase 3 | Status: COMPLETED